Literature DB >> 20122759

[New perspectives on oral preventive anticoagulants].

Belén Enfedaque Montes, Elisenda Sant i Arderiu.   

Abstract

Mesh：

Substances：

Year:  2010        PMID： 20122759      PMCID： PMC7024416          DOI： 10.1016/j.aprim.2009.11.007

Source DB:  PubMed          Journal:  Aten Primaria        ISSN： 0212-6567            Impact factor:   1.137


× No keyword cloud information.
  8 in total

Review 1.  [New oral anticoagulants: molecular characteristics, mechanisms of action, pharmacokinetics and pharmacodynamics].

Authors:  P Marco; F Tarín; J Lucas
Journal:  Med Clin (Barc)       Date:  2008-11       Impact factor: 1.725

2.  New antithrombotic drugs: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).

Authors:  Jeffrey I Weitz; Jack Hirsh; Meyer M Samama
Journal:  Chest       Date:  2008-06       Impact factor: 9.410

3.  Dabigatran versus warfarin in patients with atrial fibrillation.

Authors:  Stuart J Connolly; Michael D Ezekowitz; Salim Yusuf; John Eikelboom; Jonas Oldgren; Amit Parekh; Janice Pogue; Paul A Reilly; Ellison Themeles; Jeanne Varrone; Susan Wang; Marco Alings; Denis Xavier; Jun Zhu; Rafael Diaz; Basil S Lewis; Harald Darius; Hans-Christoph Diener; Campbell D Joyner; Lars Wallentin
Journal:  N Engl J Med       Date:  2009-08-30       Impact factor: 91.245

4.  Antithrombotic therapy in atrial fibrillation: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).

Authors:  Daniel E Singer; Gregory W Albers; James E Dalen; Margaret C Fang; Alan S Go; Jonathan L Halperin; Gregory Y H Lip; Warren J Manning
Journal:  Chest       Date:  2008-06       Impact factor: 9.410

5.  Prevention of venous thromboembolism: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).

Authors:  William H Geerts; David Bergqvist; Graham F Pineo; John A Heit; Charles M Samama; Michael R Lassen; Clifford W Colwell
Journal:  Chest       Date:  2008-06       Impact factor: 9.410

6.  Dabigatran etexilate versus enoxaparin for prevention of venous thromboembolism after total hip replacement: a randomised, double-blind, non-inferiority trial.

Authors:  Bengt I Eriksson; Ola E Dahl; Nadia Rosencher; Andreas A Kurth; C Niek van Dijk; Simon P Frostick; Martin H Prins; Rohan Hettiarachchi; Stefan Hantel; Janet Schnee; Harry R Büller
Journal:  Lancet       Date:  2007-09-15       Impact factor: 79.321

Review 7.  Current and future prospects for anticoagulant therapy: inhibitors of factor Xa and factor IIa.

Authors:  Job Harenberg; Martin Wehling
Journal:  Semin Thromb Hemost       Date:  2008-02       Impact factor: 4.180

Review 8.  Emergence of new oral antithrombotics: a critical appraisal of their clinical potential.

Authors:  Michael Rud Lassen; Volker Laux
Journal:  Vasc Health Risk Manag       Date:  2008
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.